Terms ending in 2036
Every in-force patent on Prime Merger Sub, LLC's record whose computed term ends in 2036, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,433,918 | Methods of Treating Joint Disease, Disorders, and Conditions with Tissue Inhibitors of Matrix Metalloproteinase In force · High confidence | Prime Merger Sub, LLC | In force | High confidence | |
| US 10,576,107 | Methods of Treating Joint Diseases, Disorders, and Conditions with Tissue Inhibitors of Matrix Metalloproteinases In force · High confidence | Prime Merger Sub, LLC | In force | High confidence | |
| US 11,666,606 | Methods of Treating Joint Disease, Disorders and Conditions with Tissue Inhibitors of Matrix Metalloproteinases In force · Low confidence | Prime Merger Sub, LLC | In force | Low confidence | |
| US 10,765,705 | Visco-Supplement Compositions, and Methods of Use Thereof In force · High confidence | Prime Merger Sub, LLC | In force | High confidence |
4 of 4 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.